Sara A. Byron - Concepedia

Author

Sara A. Byron

Translational Genomics Research Institute ORCID

Also Known As

Lee, Adrian V., S A Byron, S BYRON, S Byron, S. Byron, SARA A. BYRON, Sara A Byron, Sara A. Byron, Sara Ann Byron, Sara Byron

188

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Translational Genomics Research Institute University of California, San Francisco Washington University in St. Louis Neurological Surgery Mayo Clinic in Arizona

About

Sara A. Byron is an author at Translational Genomics Research Institute specializing in medicine, tumor biology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	575
2	Health Sciences	3	3	248
3	Engineering	1	1	40
4	Natural Sciences	1	1	15
5	Biostatistics	1	1	50

Sara A. Byron

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Brivanib Alaninate, a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Tyrosine Kinases, Induces Growth Inhibition in Mouse Models of Human Hepatocellular Carcinoma Hung Huynh, Van Chanh Ngo, Joseph Fargnoli, Clinical Cancer Research	2008	220
FGFR2 Point Mutations in 466 Endometrioid Endometrial Tumors: Relationship with MSI, KRAS, PIK3CA, CTNNB1 Mutations and Clinicopathological Features Sara A. Byron, Michael G. Gartside, Matthew A. Powell, PLoS ONE GynecologyPathologyFgfr2 Point MutationsTumor BiologyOncology	2012	185
Inhibition of Activated Fibroblast Growth Factor Receptor 2 in Endometrial Cancer Cells Induces Cell Death Despite PTEN Abrogation Sara A. Byron, Michael G. Gartside, Candice L. Wellens, Cancer Research	2008	149
The N550K/H Mutations in FGFR2 Confer Differential Resistance to PD173074, Dovitinib, and Ponatinib ATP-Competitive Inhibitors Sara A. Byron, Huaibin Chen, Andreas Wortmann, Neoplasia	2013	132
A pilot precision medicine trial for children with diffuse intrinsic pontine glioma—PNOC003: A report from the Pacific Pediatric Neuro‐Oncology Consortium Sabine Mueller, Payal Jain, Winnie S. Liang, International Journal of Cancer	2019	127
Insulin receptor substrates mediate distinct biological responses to insulin-like growth factor receptor activation in breast cancer cells Sara A. Byron, Kathryn B. Horwitz, Jennifer K. Richer, British Journal of Cancer	2006	118
Loss-of-Function Fibroblast Growth Factor Receptor-2 Mutations in Melanoma Michael G. Gartside, Huaibin Chen, Omar A. Ibrahimi, Molecular Cancer Research	2009	118
Enrichment of PI3K-AKT–mTOR Pathway Activation in Hepatic Metastases from Breast Cancer Mariaelena Pierobon, Corinne Ramos, Shukmei Wong, Clinical Cancer Research	2017	92
Prospective Feasibility Trial for Genomics-Informed Treatment in Recurrent and Progressive Glioblastoma Sara A. Byron, Nhan L. Tran, Rebecca F. Halperin, Clinical Cancer Research	2017	81
Correlates of clinical benefit from immunotherapy and targeted therapy in metastatic renal cell carcinoma: comprehensive genomic and transcriptomic analysis Nazlı Dizman, Yung Lyou, Nicholas Salgia, Journal for ImmunoTherapy of Cancer	2020	73

Page 1